• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
XFOR

XFOR

X4 Pharmaceuticals, Inc.

NASDAQHealthcareBiotechnologyUS

USD3.97

-0.07 (-1.73%)

Rating:C+

Company Profile

CEO

Adam R. Craig

IPO Date

2017-11-16

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$4.05

Prev. Close

$4.04

Day Low

$3.96

Day High

$4.09

52W Low

$1.35

52W High

$4.83

Market Cap

$0.37B

Volume

0.40M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

31.6%

Avg Negative

3.9%

Avg Neutral

64.5%

News Feed

X4 Pharmaceuticals to Announce Second Quarter 2021 Financial Results and Host a Conference Call and Webcast on August 3, 2021

GlobeNewsWire·7/22/2021·↑ positive

X4 Pharmaceuticals Announces Presentation of Positive Data from Ongoing Phase 1b Clinical Trial of Mavorixafor in Waldenström's Macroglobulinemia at EHA 2021

GlobeNewsWire·6/11/2021·↑ positive

X4 Pharmaceuticals Announces Positive Preliminary Data from Ongoing Phase 1b Clinical Trial of Mavorixafor in Waldenström's Macroglobulinemia as Published in EHA Abstract

GlobeNewsWire·5/12/2021·↑ positive

X4 Pharmaceuticals, Inc. (XFOR) CEO Paula Ragan on Q1 2021 Results - Earnings Call Transcript

Seeking Alpha·5/9/2021·↓ negative

X4 Pharmaceuticals to Present at the 20th Annual Needham Virtual Healthcare Conference

GlobeNewsWire·4/7/2021·↑ positive

X4 Pharmaceuticals Announces $55.0 Million At-the-Market Private Placement Financing

GlobeNewsWire·3/19/2021·↑ positive

X4 Pharmaceuticals, Inc. (XFOR) CEO Paula Ragan on Q4 2020 Results - Earnings Call Transcript

Seeking Alpha·3/4/2021·↓ negative

X4 Pharmaceuticals to Participate at the Virtual B. Riley Oncology Institutional Investor Conference

GlobeNewsWire·1/19/2021·↑ positive

X4 Pharmaceuticals to Present at the H.C. Wainwright Virtual BioConnect Conference

GlobeNewsWire·1/7/2021·↑ positive

X4 Pharmaceuticals (XFOR) Surges: Stock Moves 6.9% Higher

Zacks Investment Research·12/18/2020·↑ positive